Cardiac remodeling is defined as a group of molecular, cellular and interstitial changes that manifest clinically as changes in size, mass, geometry and function of the heart after injury. Cardiac remodeling is generally accepted as a determinant of the clinical course of heart failure.
The most common studies used to measure remodeling are:
Cardiac remodeling involves both adaptive and maladaptive phases of development. Angiotensin-converting enzyme (ACE) inhibitors have been consistently shown to decrease remodeling in animal models or transmural infarction and chronic pressure overload. Medications may attenuate remodeling.
Cardiology research Journals like Clinical Cardiology and Cardiovascular Medicine (CCCM) provides a global open access platform to put forth the ongoing research, reviews articles related to all heart related disease, its treatment, case reports and many more.